Eastgate Competitors
| ETBI Stock | USD 0.0008 0.00 0.000003% |
Eastgate Biotech vs Qrons Correlation
Moving against Eastgate Stock
| 0.71 | AMEGF | American Eagle Gold | PairCorr |
| 0.67 | FBNC | First Bancorp | PairCorr |
| 0.67 | VCUFF | Vizsla Copper Corp | PairCorr |
| 0.63 | NISTF | Nippon Steel Earnings Call Tomorrow | PairCorr |
| 0.59 | FIP | FTAI Infrastructure | PairCorr |
Eastgate Biotech Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Eastgate Biotech and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Eastgate and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Eastgate Biotech Corp does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Eastgate Stock performing well and Eastgate Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eastgate Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SCRCQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CBDL | 25.08 | 6.46 | 0.13 | 3.10 | 20.37 | 100.00 | 166.67 | |||
| LRSV | 1.71 | (0.91) | 0.00 | (2.70) | 0.00 | 0.00 | 33.33 | |||
| TSTS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| FORZ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| GPFT | 10.40 | 1.08 | 0.05 | (4.39) | 10.91 | 20.00 | 78.57 | |||
| EMED | 20.09 | 5.63 | 0.10 | (0.68) | 17.21 | 100.00 | 150.00 | |||
| DRWN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| BSYI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| QRON | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cross Equities Net Income Analysis
Compare Eastgate Biotech Corp and related stocks such as ScripsAmerica, Cbd Life Sciences, and Link Reservations Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TSTS | (1.4 K) | (1.4 K) | (15.3 K) | (54.8 K) | (787.1 K) | (787.1 K) | (787.1 K) | (787.1 K) | (787.1 K) | (787.1 K) | (787.1 K) | (787.1 K) | (787.1 K) | (787.1 K) | (787.1 K) | (708.4 K) | (673 K) |
Eastgate Biotech Corp and related stocks such as ScripsAmerica, Cbd Life Sciences, and Link Reservations Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Eastgate Biotech Corp financial statement analysis. It represents the amount of money remaining after all of Eastgate Biotech Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Eastgate Biotech Competitive Analysis
The better you understand Eastgate Biotech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Eastgate Biotech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Eastgate Biotech's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Eastgate Biotech Competition Performance Charts
Five steps to successful analysis of Eastgate Biotech Competition
Eastgate Biotech's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Eastgate Biotech Corp in relation to its competition. Eastgate Biotech's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Eastgate Biotech in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Eastgate Biotech's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Eastgate Biotech Corp, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Eastgate Biotech position
In addition to having Eastgate Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Funds Thematic Idea Now
Consumer Funds
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. The Consumer Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Eastgate Biotech Correlation with its peers. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is there potential for Biotechnology market expansion? Will Eastgate introduce new products? Factors like these will boost the valuation of Eastgate Biotech. Projected growth potential of Eastgate fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Eastgate Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Eastgate Biotech Corp's market price often diverges from its book value, the accounting figure shown on Eastgate's balance sheet. Smart investors calculate Eastgate Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Eastgate Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Eastgate Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Eastgate Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Eastgate Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.